Microdose GLP-1 uses a lower-dose, twice-weekly approach to metabolic support. Available as either compounded tirzepatide or compounded semaglutide, it offers a gentler, more manageable way to help regulate appetite and maintain balance.
Minimized Side Effects: Lower doses are much easier on the digestive tract, drastically reducing the nausea, bloating, and fatigue often experienced at full therapeutic levels.
Quells "Food Noise": Even at sub-therapeutic doses, many patients experience a significant reduction in intrusive thoughts, cravings, and reward-seeking food behaviors.
Metabolic Support: It helps gently restore metabolic signaling, improve insulin sensitivity, and balance blood sugar without forcing rapid weight loss.
Long-Term Sustainability: Easing into the medication allows the body to adjust gradually. It is also an effective strategy for maintaining previous weight loss while preventing a rebound.
Cost Effective: Using less medication overall can lower monthly prescription or compounding costs.